The Novavax COVID-19 vaccine is set to finally receive full approval from the FDA. The agency said Novavax must collect more ...

The mRNA technology behind the Pfizer and Moderna vaccines are groundbreaking, but their potential goes way beyond COVID-19.

When COVID-19 first emerged, the U.S., under President Donald Trump, made an urgent bet on vaccines — and it paid off ...

Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...

Measles could be well positioned for a comeback in the United States in a very short period of time. If immunization rates ...

Concerned that the nation’s health leadership is casting unfounded doubt on the safety of well-studied vaccines and may take ...

Global aid funding cuts, led by the United States, are disrupting efforts to vaccinate children against deadly diseases ...

You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to ...

The new FDA chief reiterated his commitment to speeding up drug approval processes and run the agency by “gold standard ...

Despite an increase in infectious disease outbreaks, the United States has cut global aid funding, which is creating a huge ...

A new study concludes excess deaths increased in Japan during the COVID-19 pandemic but does not report any explosion in ...

A team of health experts is launching an independent project that could start its own vaccine evaluation and guidelines — ...